Sign in

CIK 0001020214

  • Accelerated filer
Ticker
CERS
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
680262011
Phone
+1 925-288-6000
Business address
1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-03-10 CORASH LAURENCE M Chief Scientific Officer Exercise or conversion · Restricted Stock Unit −6,000 6,000
2018-03-10 Green Kevin Dennis Chief Financial Officer Exercise or conversion +6,000 58,062
2018-03-10 Green Kevin Dennis Chief Financial Officer Exercise or conversion · Restricted Stock Unit −6,000 6,000
2018-03-10 Menard Chrystal Chief Legal Officer Exercise or conversion +5,701 13,055
2018-03-10 Menard Chrystal Chief Legal Officer Exercise or conversion · Restricted Stock Unit −5,701 5,700
2018-03-10 Moore Carol SVP Reg. & Quality Exercise or conversion +6,000 31,583
2018-03-10 Moore Carol SVP Reg. & Quality Exercise or conversion · Restricted Stock Unit −6,000 6,000
2018-03-10 Benjamin Richard J Chief Medical Officer Exercise or conversion +3,000 4,832
2018-03-10 Benjamin Richard J Chief Medical Officer Exercise or conversion · Restricted Stock Unit −3,000 3,000
2018-03-01 Moore Carol SVP Reg. & Quality Grant or award · Option (Right to Buy) +95,000 95,000
2018-03-01 Moore Carol SVP Reg. & Quality Grant or award · Restricted Stock Unit +47,500 47,500
2018-03-01 Menard Chrystal Chief Legal Officer Grant or award · Option (Right to Buy) +95,000 95,000
2018-03-01 Menard Chrystal Chief Legal Officer Grant or award · Restricted Stock Unit +47,500 47,500
2018-03-01 Jayaraman Vivek K Chief Commercial Officer Grant or award · Option (Right to Buy) +95,000 95,000
2018-03-01 Jayaraman Vivek K Chief Commercial Officer Grant or award · Restricted Stock Unit +47,500 47,500
2018-03-01 Greenman William Mariner President and CEO Grant or award · Option (Right to Buy) +430,000 430,000
2018-03-01 Greenman William Mariner President and CEO Grant or award · Restricted Stock Unit +215,000 215,000
2018-03-01 Green Kevin Dennis Chief Financial Officer Grant or award · Option (Right to Buy) +95,000 95,000
2018-03-01 Green Kevin Dennis Chief Financial Officer Grant or award · Restricted Stock Unit +47,500 47,500
2018-03-01 CORASH LAURENCE M Chief Scientific Officer Grant or award · Option (Right to Buy) +95,000 95,000

Page 50 of 57 · 1,128 trades